Your Article Summary
Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO)
Clinical Endocrinology, 06/19/09
Timmers HJLM et al. - For tumour localization, 18F-FDA PET and 123/131I-MIBG scintigraphy perform equally well in patients with non-metastatic PHEO, but metastases are better detected by 18F-FDA PET than by 123/131I-MIBG.
Related Articles
Magnesium Sulphate as Rescue Haemodynamic Stabilizer During Phaeochromocytoma Excision
Journal of Anaesthesiology Clinical Pharmacology, 10/20/09
Relevance Score: 88%
Today in CT/SPECT/PET...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic Value of Multislice Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Retroperitoneal Spread of Testicular Cancer
Acta Radiologica, 12/04/09
Reperfusion Phenomenon Masking Acute and Subacute Infarcts at Dynamic Perfusion CT: Confirmation by Fusion of CT and Diffusion-Weighted MR Images
American Journal of Roentgenology, 12/04/09
Spectrum of 18F-FDG PET/CT Appearances in Peritoneal Disease
American Journal of Roentgenology, 12/04/09
Today in Nuclear Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Spectrum of 18F-FDG PET/CT Appearances in Peritoneal Disease
American Journal of Roentgenology, 12/04/09
The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake
International Journal of Radiation Biology, 12/04/09
Track structure effects in a study of cell killing in normal human skin fibroblasts
International Journal of Radiation Biology, 12/04/09

See Latest Articles